JP2005520480A5 - - Google Patents

Download PDF

Info

Publication number
JP2005520480A5
JP2005520480A5 JP2002507845A JP2002507845A JP2005520480A5 JP 2005520480 A5 JP2005520480 A5 JP 2005520480A5 JP 2002507845 A JP2002507845 A JP 2002507845A JP 2002507845 A JP2002507845 A JP 2002507845A JP 2005520480 A5 JP2005520480 A5 JP 2005520480A5
Authority
JP
Japan
Prior art keywords
activity
dichlorophenyl
alkyl
prop
hgf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002507845A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005520480A (ja
JP4993834B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/020849 external-priority patent/WO2002002593A2/en
Publication of JP2005520480A publication Critical patent/JP2005520480A/ja
Publication of JP2005520480A5 publication Critical patent/JP2005520480A5/ja
Application granted granted Critical
Publication of JP4993834B2 publication Critical patent/JP4993834B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002507845A 2000-06-29 2001-06-29 細胞増殖および血管形成の調節物質、その使用方法および特定方法 Expired - Fee Related JP4993834B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US60662800A 2000-06-29 2000-06-29
US09/606,628 2000-06-29
US27617001P 2001-03-15 2001-03-15
US60/276170 2001-03-15
PCT/US2001/020849 WO2002002593A2 (en) 2000-06-29 2001-06-29 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof

Publications (3)

Publication Number Publication Date
JP2005520480A JP2005520480A (ja) 2005-07-14
JP2005520480A5 true JP2005520480A5 (https=) 2008-08-14
JP4993834B2 JP4993834B2 (ja) 2012-08-08

Family

ID=28794211

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002507845A Expired - Fee Related JP4993834B2 (ja) 2000-06-29 2001-06-29 細胞増殖および血管形成の調節物質、その使用方法および特定方法

Country Status (5)

Country Link
EP (1) EP1355921A2 (https=)
JP (1) JP4993834B2 (https=)
AU (2) AU7785401A (https=)
CA (1) CA2452445C (https=)
WO (1) WO2002002593A2 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7192976B2 (en) * 2002-12-21 2007-03-20 Angion Biomedica Corporation Small molecule modulators of hepatocyte growth factor (scatter factor) activity
KR101254371B1 (ko) 2003-07-18 2013-05-02 암젠 프레몬트 인코포레이티드 간세포 성장인자에 결합하는 분리된 항체
CN100363383C (zh) * 2003-07-21 2008-01-23 中国人民解放军军事医学科学院基础医学研究所 能够与金葡菌毒力因子调控蛋白结合的小分子多肽及其医药用途
JP2008500015A (ja) * 2003-10-29 2008-01-10 ラモト アット テル アヴィヴ ユニヴァーシティ リミテッド 血管形成ペプチドおよびその使用
US20060008844A1 (en) * 2004-06-17 2006-01-12 Avidia Research Institute c-Met kinase binding proteins
US20060235034A1 (en) * 2004-11-01 2006-10-19 Nouri Neamati Novel compounds for treatment of cancer and disorders associated with angiogenesis function
US7947682B2 (en) * 2004-12-29 2011-05-24 University Of Southern California Substituted N′-pyrrolo[1,2-a]quinoxalin-4-yl-hydrazides as anti-cancer agents
WO2006052840A2 (en) * 2004-11-04 2006-05-18 University Of Virginia Patent Foundation Bone tropic peptides
ATE486872T1 (de) 2005-02-09 2010-11-15 Arqule Inc Maleimid-derivate, pharmazeutische zusammensetzungen und verfahren zur behandlung von krebs
US7879898B1 (en) 2006-02-14 2011-02-01 Angion Biomedica Corp. Hepatocyte growth factor pathway activators in chronic obstructive pulmonary disease
US8236761B2 (en) 2006-07-07 2012-08-07 Washington State University Research Foundation C-Met receptor regulation by angiotensin IV (AT4) receptor ligands
WO2008005531A2 (en) * 2006-07-07 2008-01-10 Washington State University Research Foundation C-met receptor regulation by angiotensin iv (at4) receptor ligands
JP5186632B2 (ja) 2006-10-19 2013-04-17 ブリッタ ハーディ， 血管形成を誘導するための組成物および方法
EP2392574B1 (en) 2007-06-22 2013-12-18 ArQule, Inc. Indolyl pyrrolidines for the treatment of cancer
AU2008268613A1 (en) 2007-06-22 2008-12-31 Arqule, Inc. Quinazolinone compounds and methods of use thereof
WO2009002806A1 (en) 2007-06-22 2008-12-31 Arqule, Inc. Pyrrolidinone, pyrrolidine-2, 5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
US8247374B2 (en) 2007-11-09 2012-08-21 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium using cytokines and variants thereof
JP5775452B2 (ja) 2008-07-10 2015-09-09 アンジオン バイオメディカ コーポレイション 肝細胞増殖因子（分散因子）活性の低分子モジュレーターの組成物および方法
EP3511342B1 (en) 2010-03-10 2024-01-17 Genmab A/S Monoclonal antibodies against c-met
JP2014509297A (ja) * 2010-10-05 2014-04-17 アンジオン バイオメディカ コーポレイション 肝細胞増殖因子（散乱因子）活性の小分子モジュレーターの使用方法
JP2012193155A (ja) * 2011-03-18 2012-10-11 Tohoku Univ 金属酸化物ナノ粒子の結晶面を認識することが出来るペプチド
US9290427B2 (en) 2012-01-30 2016-03-22 Universiteit Gent Anti-invasive compounds
WO2016123163A2 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease
WO2020077265A1 (en) 2018-10-12 2020-04-16 Theradaptive, Inc. Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof
CA3133803A1 (en) 2019-04-11 2020-10-15 Angion Biomedica Corp. Solid forms of (e)-3-[2-(2-thienyl)vinyl]-1h-pyrazole
BR112022020809A2 (pt) 2020-04-15 2023-02-23 Theradaptive Inc Composições e métodos para entrega terapêutica direcionada ao osso
CN115317469A (zh) * 2021-05-11 2022-11-11 四川大学 白及联菲c在制备预防和/或治疗乳腺癌或乳腺癌转移的药物中的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69334159D1 (de) * 1992-09-18 2007-09-13 Us Gov Health & Human Serv Medizinische Verwendung eines Antikörpers oder eines Antikörperfragments gegen die extrazelluläre Domäne von Met zur Prevention von Metastasen
US5646036A (en) * 1995-06-02 1997-07-08 Genentech, Inc. Nucleic acids encoding hepatocyte growth factor receptor antagonist antibodies
IL127558A0 (en) * 1996-07-03 1999-10-28 Genentech Inc Hepatocyte growth factor receptor agonists and uses thereof
WO1999046237A1 (en) * 1998-03-12 1999-09-16 Novo Nordisk A/S Modulators of protein tyrosine phosphatases
AU5382200A (en) * 1999-06-15 2001-01-02 University Health Network Muc1 ligands

Similar Documents

Publication Publication Date Title
JP2005520480A5 (https=)
CA2452445A1 (en) Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
JP2007530690A5 (https=)
RU2492167C2 (ru) Производные аминотриазола в качестве агонистов alх
JP2010533158A5 (https=)
CN103119031B (zh) 取代酰胺化合物
RU2017144535A (ru) Мультизамещенные ароматические соединения в качестве ингибиторов тромбина
JP2019537603A5 (https=)
JP2004517898A5 (https=)
US6589997B2 (en) Small-molecule modulators of hepatocyte growth factor/scatter factor activities
HU227564B1 (en) Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia for producing pharmaceutical compositions
JP2015505841A5 (https=)
AU2001277854A1 (en) Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
JP2010504280A5 (https=)
JP2008546836A (ja) 新規な用途
JP2008517976A5 (https=)
RU2018145045A (ru) Соединения бензолсульфонамида и их применение в качестве терапевтических средств
JP2019516737A5 (https=)
RU2003103780A (ru) Соединения фенилпиридазина и содержащие их лекарственные средства
JP2011500679A5 (https=)
RU2332996C2 (ru) Производные гидразонпиразола и их применение в качестве лекарственного средства
CN115884966A (zh) 双环化合物及其应用
JP2018532778A5 (https=)
US6610726B2 (en) Compositions and agents for modulating cellular proliferation and angiogenesis
JP2011524362A5 (https=)